The outbreak of the coronavirus disease 2019 (COVID-19), caused by the novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become an evolving global …

In children, the risk of coronavirus disease (COVID) being severe is low. However, the risk of
persistent symptoms following infection with severe acute respiratory syndrome coronavirus …

Importance Refinement of criteria for multisystem inflammatory syndrome in children (MIS-C)
may inform efforts to improve health outcomes. Objective To compare clinical characteristics …

Importance Information on underlying conditions and severe COVID-19 illness among
children is limited. Objective To examine the risk of severe COVID-19 illness among children …

Children and adolescents exhibit a broad range of clinical outcomes from SARS-CoV-2
infection, with the majority having minimal to mild symptoms. Additionally, some succumb to …

As severe acute respiratory syndrome coronavirus 2 continues to spread worldwide, there
have been increasing reports from Europe, North America, Asia, and Latin America …

From the beginning of the coronavirus disease 2019 (COVID-19) pandemic it became
evident that children infected with the severe acute respiratory syndrome coronavirus 2 …

Background The long-term sequelae of coronavirus disease 2019 (COVID-19) in children
remain poorly characterised. This study aimed to assess long-term outcomes in children …

Summary Background Non-pharmaceutical interventions (NPIs) were implemented by many
countries to reduce the transmission of severe acute respiratory syndrome coronavirus 2 …

Objective To characterise the clinical features of children and young people admitted to
hospital with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS …